As part of Abu Dhabi’s efforts to enhance patient outcomes,

DoH, M42, PureHealth, Illumina, NYUAD, KU and IHLAD launch strategic partnership to advance precision medicine in the Emirate

• DoH, PureHealth, Khalifa University, Illumina, M42, IHLAD and New York University Abu Dhabi have signed a landmark MoU to establish a collaborative framework that will shape the future of healthcare through precision medicine and advanced therapies
• The multi-stakeholder partnership will drive genomic innovation, AI-powered healthcare, and local talent development through cutting-edge research and clinical integration